Adenosine A2A receptor antagonist istradefylline (KW-6002) reduces "off" time in Parkinson's disease: A double-blind, randomized, multicenter clinical trial (6002-US-005) von LeWitt, Peter A., Guttman, M., Tetrud, James W., Tuite, Paul J., Mori, Akihisa, Chaikin, Philip, Sussman, Neil M.

Volltext

MPTP-induced parkinsonism: an historical case series von Nonnekes, Jorik, Post, Bart, Tetrud, James W, Langston, J William, Bloem, Bastiaan R

Volltext

The Effect of Deprenyl (Selegiline) on the Natural History of Parkinson's Disease von Tetrud, James W., Langston, J. William

Volltext

Genetic fine-mapping of the Iowan SNCA gene triplication in a patient with Parkinson’s disease von Zafar, Faria, Valappil, Ruksana Azhu, Kim, Sam, Johansen, Krisztina K., Chang, Anne Lynn S., Tetrud, James W., Eis, Peggy S., Hatchwell, Eli, Langston, J. William, Dickson, Dennis W., Schüle, Birgitt

Volltext

An Impairment in Sniffing Contributes to the Olfactory Impairment in Parkinson's Disease von Sobel, Noam, Thomason, Moriah E., Stappen, Iris, Tanner, Caroline M., Tetrud, James W., Bower, James M., Sullivan, Edith V., John D. E. Gabrieli

Volltext

Orally disintegrating selegiline in Parkinson patients with dopamine agonist-related adverse effects von Lyons, Kelly E, Friedman, Joseph H, Hermanowicz, Neal, Isaacson, Stuart H, Hauser, Robert A, Hersh, Bonnie P, Silver, Dee E, Tetrud, James W, Elmer, Lawrence W, Parashos, Sotirios A, Struck, Lynn K, Lew, Mark F, Pahwa, Rajesh

Volltext

Tolerability and efficacy of switching from oral selegiline to Zydis selegiline in patients with Parkinson’s disease von Ondo, William G, Hunter, Christine, Isaacson, Stuart H, Silver, Dee E, Stewart, R. Malcolm, Tetrud, James W, Davidson, Anthony

Volltext

A novel formulation of selegiline for the treatment of Parkinson's disease von Tetrud, James W, Koller, William C

Volltext

Pattern of dopaminergic loss in the striatum of humans with MPTP induced parkinsonism von Snow, Barry J, Vingerhoets, Francois J G, Langston, J William, Tetrud, James W, Sossi, Vesna, Calne, Donald B

Volltext

Quantification of dyskinesia in Parkinson's disease: Validation of a novel instrumental method von Burkhard, Pierre R., Shale, Heidi, Langston, J. William, Tetrud, James W.

Volltext

Voluntarily simulated tremor in normal subjects von Burkhard, Pierre R, Langston, J.William, Tetrud, James W

Volltext

Neurodegenerative disorders mimicking progressive supranuclear palsy: a report of three cases von Murphy, Marjorie A., Friedman, Joseph H., Tetrud, James W., Factor, Stewart A.

Volltext

Chronic Parkinsonism in Humans due to a Product of Meperidine-Analog Synthesis von Langston, J. William, Ballard, Philip, Tetrud, James W., Irwin, Ian

Volltext

A novel formulation of selegiline for the treatment of Parkinson's disease: The evolving role of monoamine oxidase inhibitors in the treatment of Parkinson's disease von TETRUD, James W, KOLLER, William C

Volltext

Adenosine A 2A receptor antagonist istradefylline (KW‐6002) reduces “off” time in Parkinson's disease: A double‐blind, randomized, multicenter clinical trial (6002‐US‐005)... von LeWitt, Peter A., Guttman, M., Tetrud, James W., Tuite, Paul J., Mori, Akihisa, Chaikin, Philip, Sussman, Neil M.

Volltext

Autopsy-proven progressive supranuclear palsy in two siblings von TETRUD, J. W, GOLBE, L. I, FORNO, L. S, FARMER, P. M

Volltext

Response : Deprenyl and the Progression of Parkinson's Disease von Tetrud, James W., Langston, J. W.

Volltext

Blood lactate in Parkinson's disease von Di Monte, Donato, Tetrud, James W., Langston, J. William

Volltext

Stelazine versus Selegiline — A Hazard in Prescription Writing von Kurth, M C, Langston, J W, Tetrud, J W

Volltext

Deprenyl and the Progression of Parkinson's Disease von Friedhoff, Arnold J., Sudarsky, Lewis, Tetrud, James W., Langston, J. W.

Volltext